期刊文献+

自身免疫性肝炎合并肝纤维化指标异常对疾病预后判断意义 被引量:3

The Significance of Abnormal Serum Fibrosis Index to the Prognosis of Autoimmune Hepatitis
下载PDF
导出
摘要 目的分析32例自身免疫性肝炎(AIH)的临床特点,探讨血清肝纤维化指标与疾病严重程度的关系,以预测预后。方法收集我院自2004年1月~2009年8月经确诊的AIH患者的住院资料,着重对临床表现进行回顾性分析。结果共32例入组病人,其中肝纤维化指标增高者共20例,正常者12例,分别检测两组的丙氨酸氨基转氨酶(ALT)、天门冬氨酸氨基转氨酶(AST)、总胆红素(TBil)、碱性磷酸酶(AKP)、γ-谷氨酰转肽酶(γ-GT)、凝血酶原时间(PT)、白细胞(WBC)、ANA效价对数、IgG、IgA水平,其中两组ALT值分别为383±305U/L、150±93U/L,AST分别为275±139U/L、156±140U/L,ANA效价对数分别为2.07±0.57g/L、1.60±0.16g/L、IgG为22.9±6.45g/L、12.1±4.17g/L,差异显著(P<0.05)。结论肝纤维谱指标反映病情严重程度,与血清透明质酸、Ⅲ型前胶原末端肽正常组比较,指标偏高组临床表现重,可以指导治疗及预测预后。 Objective To analyze the clinical features of 32 autoimmune hepatitis patients,and discuss the relationship between serum fibrosis index and the severity of disease in order to predict the prognosis. Methods We collected the data of the patients with auto- immune hepatitis who were diagnosised in the First Affiliated Hospital of Wenzhou Medical College from January 2004 to March 2009. And the analysis was focused on retrospective analysis of clinical manifestations. Results A total of 32 patients were enrolled in this study. Of those cases,liver fibrosis indexes in 20 cases were increased, and 12 patients were normal. ALT, AST, TB, AKP, γ-GT, PT, WBC, ANA titer log, IgG, IgA levels were detected in the two groups. The ALT value in two groups was 383 ± 305U/L, 150 ± 93U/L,respectively. The AST value in two groups was 275 ± 139U/L, 156 ± 140U/L respectively, and ANA titer log was 2.07 ±0.57,1.60± 0.16 respectively, and IgG value was 22.9 ± 6.45g/L, 12.1 ± 4.17g/L respectively. The difference was significant ( P 〈 0.05 ). Conclusion Compared with normal group,the clinical manifestations of patients with high serum hyaluronie acid and III procollagen propeptide were more serious. Indexes of liver fibrosis can reflect the severity of disease, and can guide treatment and predict prognosis.
出处 《医学研究杂志》 2010年第5期97-100,共4页 Journal of Medical Research
关键词 自身免疫性肝炎 肝纤维化指标 病情 Autoimmune hepatitis Serum fibrosis index State of an illness
  • 相关文献

参考文献17

  • 1Czaja AJ, Freese DK. Diagnosis and Treatment of Autoimmune Hepatitis. Hepatology, 2002, 36 (2):481 -497.
  • 2Johnson PJ, Mcfarlane IG. Meeting report: International Autoimmune Hepatitis Group. Hepatology, 1993,18:998 - 1005.
  • 3於强,王吉耀,姜林娣,张锦生.自身免疫性肝炎的临床和病理[J].中华肝脏病杂志,2000,8(1):43-44. 被引量:30
  • 4王吉耀.内科学.北京:人民出版社,2006,1:696.
  • 5Choudhuri G,Somani SK,Baba CS,et al. Autoimmune hepatitis in India : profile of an uncommon disease. BMC Gastroenterol,2005,15:27.
  • 6Omagari K, Kinoshita H, Kato Y ,et al. Clinical features of 89 patients with autoimmune hepatitis in Nagasaki Prefecture, Japan. J Gastroenterol, 1999,34:221 - 226.
  • 7王锦辉,陈旻湖.自身免疫性肝炎的诊断和治疗进展[J].广东医学,2008,29(7):1078-1079. 被引量:14
  • 8陆伦根,曾民德.肝纤维化的诊断和评估[J].中华肝脏病杂志,2005,13(8):603-604. 被引量:100
  • 9Zheng M, Cai W, Weng H ,et al. Determination of serumfibrosis indexes in patients with chronic and its significance. Chin Med J,2003, 116(3) :346 -349.
  • 10Patel K, Lajoie A ,Heaton S ,et al. Clinical use of hyaluronic acid as a predictor of fibrosis in hepatitis C. J Gastroenterol Hcpatol,2003,18 (3) :253 -257.

二级参考文献13

共引文献510

同被引文献28

  • 1李旭,杨希山,吴平生,孟莹,李素梅,李先茂,赖文岩,张虹,Yoshiyu Takeda,lsamu Miyamon,Byoyu,Takeda.肝储脂细胞表达CYP11B2mRNA与实验性肝纤维化的关系研究[J].现代消化及介入诊疗,1999,4(3):12-16. 被引量:1
  • 2丁贤君,李世波,李绍佐,刘华生,刘波,徐方明,顾若薇.慢性肝病患者肝纤维化血清学指标与肝组织纤维化分期的量化关系[J].中华肝脏病杂志,2005,13(12):911-914. 被引量:25
  • 3马岚青,段丽平,张林,李树安,梁兵,董向前,詹尔益,杨志伟,张肇久,魏咏敏,吴秀娟,晋德光.人参皂苷Rb_1对肝纤维化血清学指标及病理学改变的相关性分析[J].云南中医学院学报,2007,30(2):28-32. 被引量:3
  • 4段丽平,马岚青,李树安,董向前,梁兵,张林,詹尔益,杨志伟,张肇久,魏咏敏,吴秀娟,晋德光.人参皂苷Rbl抗肝纤维化的实验研究[J].中西医结合肝病杂志,2007,17(3):156-158. 被引量:4
  • 5于婧,毛齐学,于虹,等.检测血清IgA、IgG、IgM对脂肪肝纤维化诊断与预后的影响[J].健康之路,2013,12(2):248.
  • 6Manns MP,Strassburg CP. Autoimmune hepatitis:clinical challenges[J].Gastroenterology,2001.1502-1505.doi:10.1053/gast.2001.24227.
  • 7Czaja AJ,Freese DK. Diagnosis and treatment of autoimmune hepatitis[J].Hepatology,2002,(02):479-497.doi:10.1053/jhep.2002.34944.
  • 8Heathcote EJ. Management of primary biliary cirrhosis.The American Association for the Study of Liver Disease practice guidelines[J].Hepatology,2000,(04):1005-1013.doi:10.1053/he.2000.5984.
  • 9Manns MP,Czaja AJ,Gorham JD. Diagnosis and management of autoimmune hepatitis[J].Hepatology,2010,(06):2193-2213.doi:10.1002/hep.23584.
  • 10Martinez SM,Crespo G,Navasa M. Noinvasive assessment of liver fibrosis[J].Hepatology,2011,(01):325-335.doi:10.1002/hep.24013.

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部